CPHI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Home Market News Antidepressant Market in the US 2015-2019: Key Vendors are Actavis, Eli Lilly, GSK, Otsuka Pharmaceutical and Pfizer
News
5 Feb 2015

Antidepressant Market in the US 2015-2019: Key Vendors are Actavis, Eli Lilly, GSK, Otsuka Pharmaceutical and Pfizer

Research and Markets has announced the addition of the "Antidepressant Market in the US 2015-2019" report to their offering.

 

Increased awareness of depression among the medical community, patients, and the families of patients is one major trend in this market. This can result in an increase in the number of treatment-seeking patients, which, in turn, can result in an increase in the overall consumption of medicines.

 

According to the report, an increase in patient population and changes in lifestyles are major factors propelling the growth of the market. Current treatment options do not provide a cure for the disorder, hence, there is a significant unmet need in the market. Therefore, drugs that can cause remission of depression in patients are expected to drive the growth of the market.

 

Further, the report states that one of the major challenges in the market is the expiry of the patents of major branded drugs, which is expected to lead to the erosion of their market share and a fall in the revenue generated by them. This is also expected to impact the size of the Antidepressant market in the US.

 

The study was conducted using an objective combination of primary and secondary information, including inputs from key participants in the industry.

Key Topics Covered:

01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
04. Product Profiles
05. Market Research Methodology
06. Introduction
07. Disorder Overview
08. Market Landscape
09. Market Segmentation by Mechanism of Action
10. Buying Criteria
11. Market Growth Drivers
12. Drivers and their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
16. Trends and their Impact
17. Vendor Landscape
18. Key Vendor Analysis
19. Other Reports in this Series

 

Companies Mentioned:

Abbott Laboratories
Actavis
AstraZeneca
Aurobindo Pharma
Bristol-Myers Squibb
Dr. Reddy's Laboratories
Eli Lilly and Company
GlaxoSmithKline
H. Lundbeck
Janssen Pharmaceuticals
Lupin
Novartis
Otsuka Pharmaceutical
Pfizer
Pierre Fabre
Shire
Somerset Pharmaceuticals
Sun Pharmaceutical
Sunovion Pharmaceuticals
Takeda Pharmaceutical
Teva Pharmaceutical
Torrent Pharmaceuticals
Valeant Pharmaceuticals

Related tags
Market

Related News